AS03
AS03 has been studied in 3 papers since 2021: none in people yet, 1 in animals, 2 reviews; 1 in the past year. The research so far is in animals. The newest paper, Nov 14, 2026: “Immunosenescence and vaccine adjuvants in older adults: from immune decline to signal reconstitution strategies”.
3 papers study itUpdated
1 new paper in 30 daysSee all 3 papers on AS03
- Animals1
Latest
1 paper in 12 monthsClinical Infectious Diseases
Precision Vaccine Adjuvants for Older Adults: A Scoping Review
Systematic reviewInterventions
Science Translational Medicine
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Experiments in miceInterventions